Arip MT 5 Tablet is an antipsychotic medicine. It is used in the treatment of schizophrenia (a mental disorder that can result in hallucinations or delusions and also adversely affects a person’s ability to think and behave) and mania. It can also be used to treat depression and bipolar disorders.
“Dabur Sitopaladi Churna 60gm” has been added to your cart. View cart
-10%

Febugood 80 Tablet
₹249.65 Original price was: ₹249.65.₹224.69Current price is: ₹224.69.

Metride DS 2 Tablet PR
₹241.50 Original price was: ₹241.50.₹217.35Current price is: ₹217.35.
Arip MT 5 Tablet
₹156.00 Original price was: ₹156.00.₹140.40Current price is: ₹140.40.
Categories: Elderly Care, Respiratory Care
Description
Reviews (0)
Be the first to review “Arip MT 5 Tablet” Cancel reply
Related products
Baidyanath Tribhuwan Keerti Ras Tablet
Dabur Mahamanjisthadi Kwath Kadha
- It helps improve skin health and improves conditions such as eczema and boils
- it can help purify the blood and lymphatic system, helping to flush out toxins from the body
- Its anti-infective properties help combat bacterial and viral infections
- Some of the herbs in this kadha have anti-inflammatory properties, which may help reduce inflammation and swelling
Dabur Ras Manikya
Dabur Shwaasamrit
Dabur Siddha Makardhwaj Tablet
- It aids in improving immunity and helps in anti-ageing
- Siddha Makardhwaja is useful in treating weakness, chronic skin conditions and other lung conditions like chronic cold, Pneumonia, or Tuberculosis
- It is used as a convalescence medicine that will help in improving strength
- It is used to rejuvenate chronic conditions and to boost energy levels especially in old age
Dabur Sitopaladi Churna 60gm
- his product may help in relieving cough and cold symptoms naturally
- It can help assist in soothing the throat and providing comfort during seasonal changes
- It may also help support respiratory health by balancing the body's natural processes
- It contains warming herbs that may help ease breathing and reduce discomfort
Reviews
There are no reviews yet.